RJ Biotech Ltd. said its normalized net income for the fiscal third quarter ended Dec. 31, 2014, came to 41 Indian paise per share, a gain of 16.6% from 35 paise per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 3.9 million rupees, a decline of 14.5% from 4.6 million rupees in the prior-year period.
The normalized profit margin fell to 5.2% from 10.6% in the year-earlier period.
Total revenue rose 72.4% year over year to 74.5 million rupees from 43.2 million rupees, and total operating expenses rose year over year to 59.5 million rupees from 28.5 million rupees.
Reported net income fell 14.5% on an annual basis to 6.3 million rupees, or 66 paise per share, from 7.3 million rupees, or 57 paise per share.
As of Feb. 4, US$1 was equivalent to 61.82 Indian rupees.
